Company patents
Antares Pharma, Inc.
Antares Pharma, Inc. demonstrates a strong and consistent focus on Drug Delivery Devices, which constitutes 83.3% of its patent portfolio, despite a -33.3% decline in patenting activity so far in 2026. While Pharmaceutical Preparations also represents a significant 45.0% of its portfolio, the company appears to be shifting away from Therapeutic Activity (Pharma), which saw a -100.0% decline in 2025, indicating a strategic de-emphasis on this area.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
60 US filings (since 2023) · 3 categories · 2 themes
Mechanical or electromechanical systems designed for precise, often self-administered, delivery of medicaments, including features for dose setting, needle insertion/retraction, and safety mechanisms to prevent premature activation.
Delivery systems specifically engineered to administer advanced drug formulations (e.g., microparticles, biologics, extended-release systems) to achieve precise targeting, controlled release kinetics, or enhanced therapeutic efficacy within the body.
Patents
Showing 1-10 of 88